Insomnia is one of the most common mental disorders and has shown an upward trend in recent years. The commonly used western medicine treatment methods are easy produce drug-related adverse reactions, and there are problems such as the decline of efficacy and the production of drug dependence after long-term medication. Traditional Chinese medicine treatment of insomnia on syndrome differentiation. In this study, taking the common heart and spleen deficiency syndrome and liver depression transforming into fire syndrome as examples, based on the theory of zangfu andingluo, we explored the selection of acupoints for acupuncture treatment of insomnia and conducted clinical efficacy observation. Combined with the analysis of the changes of Pittsburgh Quality Index, Hamilton Anxiety Scale, Traditional Chinese Medicine Syndrome Efficacy Rating, Infrared Thermal Image Acquisition, Forehead Adhesive Sleep Recorder and other data, the acupuncture treatment of insomnia patients was expounded.

Inclusion Criteria:

• Meets the diagnostic criteria for insomnia in both Western and traditional Chinese medicine and the classification criteria for TCM syndrome differentiation;
• Between 16 and 30 years old (including 16 and 30 years old);
• No mental or language disorders;
• PQSI score ≥ 7;
• No hypnotic medication treatment within two weeks before the study;
• Patient informed consent, and voluntarily participate in this.

Exclusion Criteria:

• Those who do not meet the above inclusion criteria;
• Those with secondary insomnia caused by organic diseases, mental diseases etc.;
• Those who faint at acupuncture or refuse acupuncture;
• Those who have received any facial acupuncture or thread embedding within 3 months;
• Those who have received radiofrequency or laser wrinkle removal treatment within half a year;
• Those who have received facial tissue filler injection and A-type botulinum toxin injection and other long-term facial rejuvenation treatment within one year;
• Pregnant or lactating, those preparing for pregnancy during the treatment process;
• Those who work night shifts for a long time, with irregular work and rest;
• Those withocrine function, immune function diseases, and those with severe primary diseases of the heart, brain, liver, kidney and hematopoietic system;
• Those who cannot cooperate with the treatment. Note: Those who meet any of the above items are not included in this trial.